Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

Completed · Phase 4

Conditions studied: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1

In brief

This study is an open label, prospective, randomised comparative, single center study. In the present study, the impact of a 12-week pulsatile insulin infusion therapy (PIT) with Humulin R 100 from

Key facts

Study ID
NCT04030091
Run by
Sciema UG
People needed
24
Starts
2019-09-06
Expected to finish
2020-12-31
Last updated by the study team
2021-04-01

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.